Central Valley Advisors LLC lowered its position in Tilray Brands, Inc. (NASDAQ:TLRY – Free Report) by 91.1% during the 4th quarter, Holdings Channel reports. The fund owned 13,067 shares of the company’s stock after selling 133,000 shares during the period. Central Valley Advisors LLC’s holdings in Tilray Brands were worth $118,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Tudor Investment Corp ET AL acquired a new stake in Tilray Brands in the third quarter valued at approximately $518,000. Swiss Life Asset Management Ltd raised its position in shares of Tilray Brands by 222.9% during the third quarter. Swiss Life Asset Management Ltd now owns 42,503 shares of the company’s stock worth $74,000 after purchasing an additional 29,339 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Tilray Brands by 99,204,800.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 992,049 shares of the company’s stock worth $1,716,000 after purchasing an additional 992,048 shares in the last quarter. Sassicaia Capital Advisers LLC bought a new position in shares of Tilray Brands in the 3rd quarter worth $401,000. Finally, Scientech Research LLC acquired a new stake in Tilray Brands in the 3rd quarter valued at $1,748,000. Institutional investors and hedge funds own 9.35% of the company’s stock.
Tilray Brands News Summary
Here are the key news stories impacting Tilray Brands this week:
- Positive Sentiment: Company set an earnings date and investor webcast (clear catalyst; opportunity for upside if results beat expectations). Read More.
- Neutral Sentiment: Company reiterated webcast details and corporate positioning (global CPG/cannabis/beverage/wellness footprint); useful for investors who follow management commentary on strategy and region-specific performance. Read More.
- Neutral Sentiment: Multiple short‑interest data feeds flagged a “large increase” for March but show zero/NaN values — appears to be a reporting/data error. This inconsistency is unlikely to reflect actual new short positioning but could cause confusion or transient volatility in low‑information periods.
- Negative Sentiment: The company did not provide any preliminary metrics or guidance with the announcement; absence of expectations increases the chance of heightened volatility when results are released. Read More.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on TLRY
Tilray Brands Stock Up 4.2%
Shares of NASDAQ:TLRY opened at $6.94 on Thursday. The stock has a market cap of $808.58 million, a price-to-earnings ratio of -0.31 and a beta of 1.96. The company has a quick ratio of 1.72, a current ratio of 2.81 and a debt-to-equity ratio of 0.19. Tilray Brands, Inc. has a 12-month low of $3.51 and a 12-month high of $23.20. The business’s 50 day moving average is $7.66 and its 200 day moving average is $10.42.
Tilray Brands (NASDAQ:TLRY – Get Free Report) last announced its quarterly earnings results on Thursday, January 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.12. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The business had revenue of $217.51 million during the quarter, compared to the consensus estimate of $211.15 million. During the same quarter in the prior year, the company posted ($0.03) earnings per share. On average, sell-side analysts forecast that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.
Tilray Brands Profile
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Read More
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Brands, Inc. (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
